Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients with Neuroendocrine Tumors A Nonrandomized Clinical Trial
Daniel M. Halperin,Suyu Liu,Arvind Dasari,David Fogelman,Priya Bhosale,Armeen Mahvash,Jeannelyn S. Estrella,Laura Rubin,Ajaykumar C. Morani,Mark Knafl,Tim A. Overeem,Szu-Chin Fu,Luisa M. Solis,Edwin Parra Cuentas,Anuj Verma,Hong-Lei Chen,Swati Gite,Priya Subashchandrabose,Shannon Dervin,Katja Schulze,Walter C. Darbonne,Cindy Yun,Ignacio I. Wistuba,P. Andrew Futreal,Scott E. Woodman,James C. Yao JAMA ONCOLOGY(2022)
AI 理解论文
溯源树
样例
